Checkpoint inhibitor monotherapy in potentially trial-eligible or trial-ineligible metastatic NSCLC patients in the German prospective CRISP Registry real-world cohort (AIO-TRK-0315)
JTO Clinical and Research Reports（2023）
关键词
Non-Small-Cell-Lung Carcinoma,Prospective Studies,Immune Checkpoint Inhibitors,Pembrolizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要